Rational Drug Use and Antimicrobial Stewardship: Introduction 101
SKS Medication Safety Series, Chapter 3 of 15 · Standard SİY01.02
Prof. Dr. Mehmet Nurullah Kurutkan, Düzce Üniversitesi İşletme Fakültesi Sağlık Yönetimi Bölümü
Chapter at a glance
Rational drug use means the right medicine, for the right indication, at the right dose and duration. In hospitals the two most studied forms are antimicrobial stewardship and the avoidance of potentially inappropriate medications in older adults. This chapter covers both. It corresponds to the SKS SİY01.02 duties of the medication management team: setting principles for rational use and preparing an antibiotic use control and prophylaxis guide (Sağlık Bakanlığı, 2020).
Evidence base: 245 records of a 4948-record Web of Science corpus on hospital medication safety (Section 7). Reading time: about 25 minutes. Prior knowledge required: none.
Learning objectives
After working through this chapter, the reader should be able to:
- define rational drug use and antimicrobial stewardship;
- describe the main stewardship strategies used in hospitals;
- explain potentially inappropriate medication and how it is screened;
- evaluate evidence on the safety effects of stewardship and deprescribing.
Key concepts
- Rational drug use (Akılcı ilaç kullanımı): use of medicines appropriate to clinical need, dose, duration and cost
- Antimicrobial stewardship programme (ASP): coordinated interventions to optimise antimicrobial use
- Surgical antibiotic prophylaxis: short antibiotic course given to prevent surgical site infection
- Potentially inappropriate medication (PIM): a drug whose risk outweighs its benefit, especially in older adults
- Deprescribing: planned withdrawal of medicines that are no longer beneficial
Contents: How this chapter was produced · 1. Introduction · 2. History and development · 3. Definitions and conceptual schema · 4. Distinguishing it from neighbouring concepts · 5. Types and classifications · 6. Theoretical frameworks and models · 7. Themes and bibliometric profile · 8. The situation in Türkiye · 9. Debates and contradictions in the literature · 10. Measurement problems · 11. Research gaps and agenda · 12. Implications for practice today · Summary · Discussion questions · Further reading · Glossary · References · Source verification and AI use statement · Data and supplementary material
How this chapter was produced
Box 1. Method
Database: Web of Science Core Collection (SCI-EXPANDED, SSCI, ESCI); English; articles and reviews (including early access). Search date: 16 November 2026; all years (1981 to 2027).
Search: (#1 medication safety and error terms AND #2 hospital settings AND #3 fifteen SKS content blocks) NOT #4 animal and preclinical terms; the full string is on the series hub.
Screening: five export files (4955 records) were merged; 7 duplicates were removed by WoS accession number, DOI and normalised title plus year, leaving 4948 records. Records were assigned to this sub-topic when its term set (rational drug use, stewardship, antibiotic or antimicrobial prophylaxis, inappropriate prescribing, potentially inappropriate medication) appeared in the title or keywords; a record can belong to several sub-topics. Included here: 245 records (101 with the term in the title; 40 reviews).
Limitations: single database; English only; assignment by term matching, checked by reading titles of the most cited and most recent records; claims are checked against abstracts, not full texts.
4955 records
101 title matches; 40 reviews
other chapters or general records
1. Introduction
Every unnecessary antibiotic carries two risks: harm to the patient through adverse events and harm to everyone through resistance. A review in the corpus argues that stewardship programmes are best placed to lead efforts against antibiotic-associated adverse drug events because overuse is the main driver of both problems (Bauer et al., 2019). The same logic applies to older patients receiving many medicines: polypharmacy and inappropriate prescribing were highly prevalent in elderly internal medicine patients, and the authors concluded that appropriate prescribing may matter more than simply reducing the number of drugs (Schuler et al., 2008).
SKS asks the medication management team to set principles for rational use and to prepare an antibiotic use control and prophylaxis guide (Sağlık Bakanlığı, 2020). This chapter explains what the literature says about how to do this.
2. History and development
The earliest records concern surgical prophylaxis, where timing and duration of antibiotics were already a quality target in 2001 (Burke, 2001), and pharmacist-managed prophylaxis was linked to clinical and economic outcomes by 2007 (Bond & Raehl, 2007). In parallel, computerised decision support was tested against inappropriate prescribing (Tamblyn et al., 2003). From the 2010s stewardship broadened to neonatal units (Patel & Saiman, 2012), to non-restrictive models such as handshake stewardship (Hurst et al., 2016) and to penicillin allergy delabelling (Blumenthal et al., 2017). Recent work defines the role of nurses (Van Huizen et al., 2021) and tests electronic deprescribing in trials (McDonald et al., 2022).
- 2001 Maximising appropriate surgical antibiotic prophylaxis (Burke, 2001).
- 2003 MOXXI: computerised support reduces initiation of inappropriate prescriptions (Tamblyn et al., 2003).
- 2010 Inappropriate prescribing in hospitalised older patients defined (Page et al., 2010).
- 2016 Handshake stewardship: rounding-based, non-restrictive model (Hurst et al., 2016).
- 2017 Penicillin allergy tools as stewardship interventions (Blumenthal et al., 2017).
- 2021 Scoping review of the nurse’s role in stewardship (Van Huizen et al., 2021).
- 2022 MedSafer cluster trial of deprescribing decision support (McDonald et al., 2022).
3. Definitions and conceptual schema
| Source | Year | Discipline | Definition (paraphrased) | Emphasised dimension |
|---|---|---|---|---|
| Sağlık Bakanlığı, 2020 | 2020 | Accreditation standard | Principles of rational drug use and an antibiotic use control and prophylaxis guide set by the medication management team. | Hospital rule-setting |
| Bauer et al., 2019 | 2019 | Infectious diseases | Stewardship as the lead for preventing antibiotic-associated adverse drug events and resistant infections. | Patient safety |
| Hurst et al., 2016 | 2016 | Paediatric infectious diseases | Daily in-person review of antimicrobial use with prescribers, without preauthorisation. | Collaborative feedback |
| Page et al., 2010 | 2010 | Geriatrics | Inappropriate prescribing as use of drugs with more risk than benefit, assessed with screening tools. | Risk-benefit in older adults |
| Van Huizen et al., 2021 | 2021 | Nursing | Nurses’ work practices, from specimen collection to administration timing, as part of stewardship. | Interprofessional role |
medicines are chosen and continued only when their expected benefit exceeds their risk for the patient and for society
The definitions agree on benefit over risk but split by population: stewardship thinks of resistance as a societal harm (Bauer et al., 2019), whereas the PIM literature focuses on the individual older patient (Page et al., 2010).
4. Distinguishing it from neighbouring concepts
Rational use overlaps most with prescribing and with interactions (Figure 4), because the main levers are prescribing decisions and the main harms include drug-drug interactions in polypharmacy (Haerig et al., 2023).
| Neighbouring concept | How it differs |
|---|---|
| Prescribing errors (SİY05) | An error is a failure in a decision; inappropriate use can be a correctly executed but poor choice (Page et al., 2010). |
| Infection control | Prevents transmission; stewardship optimises antimicrobial use (Bauer et al., 2019). |
| Formulary (SİY02) | Determines availability; stewardship governs use of available drugs (Hurst et al., 2016). |
| Drug interactions (SİY03) | One mechanism through which inappropriate polypharmacy causes harm (Haerig et al., 2023). |
5. Types and classifications
Stewardship strategies fall into restrictive (preauthorisation, formulary restriction) and persuasive approaches (audit and feedback, rounding). Handshake stewardship is a persuasive model that reduced antimicrobial use hospital-wide (Hurst et al., 2016). Diagnostic strategies, such as penicillin allergy testing and computerised guidelines, increased use of preferred beta-lactams (Blumenthal et al., 2017). For older adults, interventions are screening tools and electronic decision support for PIMs (McDonald et al., 2022; Scott et al., 2018).
6. Theoretical frameworks and models
Stewardship literature frames antibiotic use as a patient safety problem in the sense of doing no harm (Bauer et al., 2019). Decision support studies rely on the idea that timely information changes prescribing behaviour (Tamblyn et al., 2003). The nurse-role literature uses an interprofessional practice frame (Van Huizen et al., 2021).
7. Themes and bibliometric profile
The bibliometric profile (Figure 5) shows growth after 2015 driven by stewardship. The evidence on patient outcomes is uneven: computerised support reduced the initiation of inappropriate prescriptions but had a more selective effect on stopping them (Tamblyn et al., 2003), and electronic decision support was feasible but produced modest absolute effects on PIM prescribing (Scott et al., 2018).
Records per year 2026 (incomplete)
Most frequent journals
Most frequent countries
Most frequent author keywords: antimicrobial stewardship (41), polypharmacy (29), medication errors (27), inappropriate prescribing (24), potentially inappropriate medications (22), patient safety (18), medication safety (17), antibiotic stewardship (16), adverse drug events (14), medication reconciliation (14).
8. The situation in Türkiye
Three records have Turkish authors. A study at Gaziantep University assessed nurses’ attitudes to rational drug use, stressing that nurses receive orders and prepare and administer drugs (Oguz et al., 2015), and another described patient-nurse-physician-pharmacist collaboration in drug administration in a military teaching hospital (Köse et al., 2012). Turkish outcome evaluations of stewardship are not present in the corpus.
9. Debates and contradictions in the literature
Fewer drugs or better drugs? In older inpatients appropriate prescribing may matter more than reducing drug counts (Schuler et al., 2008). Yet in older adults with cancer, polypharmacy and PIM use were common but not associated with chemotherapy toxicity or hospitalisation (Maggiore et al., 2014), while another cohort found PIM and interaction exposure associated with falls and admission but not death (Haerig et al., 2023).
Process change or patient outcome? A cluster randomised trial of deprescribing decision support improved deprescribing but showed no demonstrable effect on adverse drug events (McDonald et al., 2022).
Restriction or collaboration? Guidelines often recommend preauthorisation, but a non-restrictive handshake model achieved wide reductions in use (Hurst et al., 2016).
10. Measurement problems
Stewardship is usually measured by consumption (for example days of therapy), which is a process indicator; safety outcomes such as antibiotic-associated adverse events are recommended but less often reported (Bauer et al., 2019; Patel & Saiman, 2012). PIM research depends on explicit criteria lists, which differ between countries and may not capture clinical appropriateness (Page et al., 2010).
11. Research gaps and agenda
- Do stewardship programmes in Turkish hospitals reduce antibiotic-associated adverse drug events? (no Turkish outcome study in the corpus)
- Which PIM criteria best predict harm in hospitalised older adults? (Haerig et al., 2023; Maggiore et al., 2014)
- Can deprescribing support be designed to reduce adverse drug events, not only drug counts? (McDonald et al., 2022)
- What is the measurable contribution of nurses to stewardship outcomes? (Van Huizen et al., 2021)
- How should SKS prophylaxis guides be audited for timing and duration? (Burke, 2001)
12. Implications for practice today
An SKS-compliant antibiotic guide is a start, not an end. The evidence supports adding daily review with prescribers (Hurst et al., 2016), penicillin allergy assessment (Blumenthal et al., 2017), pharmacist management of surgical prophylaxis (Bond & Raehl, 2007) and nurse participation (Van Huizen et al., 2021). For older patients, screening for PIMs at admission is useful when linked to a clear clinical review (Scott et al., 2018).
Summary
- Rational use covers antimicrobials and potentially inappropriate medications.
- SKS assigns rational use principles and an antibiotic guide to the medication team.
- Persuasive stewardship can be as effective as restrictive approaches.
- Deprescribing support changes prescribing but has not yet shown fewer adverse events.
- Turkish evidence focuses on attitudes, not outcomes.
Discussion questions
- Why is antibiotic overuse both a patient safety and a public health problem?
- Compare restrictive and persuasive stewardship strategies.
- Why might PIM use not predict harm in some cohorts?
- Design an audit of the SKS prophylaxis guide in a surgical department.
- What role could ward nurses play in your hospital’s stewardship programme?
Further reading
- (Bauer et al., 2019): links stewardship directly to patient safety.
- (Hurst et al., 2016): an influential non-restrictive stewardship model.
- (Page et al., 2010): a clear introduction to inappropriate prescribing in hospital.
- (McDonald et al., 2022): a rigorous trial with an instructive null result.
- (Van Huizen et al., 2021): maps the nurse’s role in stewardship.
Glossary
| Turkish | English | Short definition |
|---|---|---|
| Akılcı ilaç kullanımı | Rational drug use | Use of medicines matched to need, dose, duration and cost |
| Antimikrobiyal yönetim programı | Antimicrobial stewardship programme | Coordinated optimisation of antimicrobial use |
| Cerrahi profilaksi | Surgical prophylaxis | Preventive antibiotic around surgery |
| Potansiyel uygunsuz ilaç | Potentially inappropriate medication | Drug with more risk than benefit for the patient |
| İlaç azaltma | Deprescribing | Planned withdrawal of non-beneficial drugs |
References
Bauer, K. A., Kullar, R., Gilchrist, M., & File, T. M. (2019). Antibiotics and adverse events: the role of antimicrobial stewardship programs in 'doing no harm'. Current Opinion in Infectious Diseases, 32(6), 553-558. https://doi.org/10.1097/QCO.0000000000000604
Blumenthal, K. G., Wickner, P. G., Hurwitz, S., Pricco, N., Nee, A. E., Laskowski, K., Shenoy, E. S., & Walensky, R. P. (2017). Tackling inpatient penicillin allergies: Assessing tools for antimicrobial stewardship. Journal of Allergy and Clinical Immunology, 140(1), 154. https://doi.org/10.1016/j.jaci.2017.02.005
Bond, C. A., & Raehl, C. L. (2007). Clinical and economic outcomes of pharmacist-managed antimicrobial prophylaxis in surgical patients. American Journal of Health-System Pharmacy, 64(18), 1935-1942. https://doi.org/10.2146/ajhp060631
Burke, J. P. (2001). Maximizing appropriate antibiotic prophylaxis for surgical patients: An update from LDS Hospital, Salt Lake City. Clinical Infectious Diseases, 33, S78-S83. https://doi.org/10.1086/321861
Haerig, T. R., Krause, D., Klaassen-Mielke, R., Rudolf, H., Trampisch, H. J., & Thuermann, P. (2023). Potentially inappropriate medication including drug-drug interaction and the risk of frequent falling, hospital admission, and death in older adults-results of a large cohort study (getABI). Frontiers in Pharmacology, 14, Article 1062290. https://doi.org/10.3389/fphar.2023.1062290
Hurst, A. L., Child, J., Pearce, K., Palmer, C., Todd, J. K., & Parker, S. K. (2016). Handshake Stewardship A Highly Effective Rounding-based Antimicrobial Optimization Service. Pediatric Infectious Disease Journal, 35(10), 1104-1110. https://doi.org/10.1097/INF.0000000000001245
Köse, G., Subasi, Ü., Hatipoglu, S., Lenk, H., & Gönül, E. (2012). The importance of patient-nursephysician- pharmacist collaboration on drug administrations. Marmara Pharmaceutical Journal, 16(2), 115-119. https://doi.org/10.12991/201216409
Maggiore, R. J., Dale, W., Gross, C. P., Feng, T., Tew, W. P., Mohile, S. G., Owusu, C., Klepin, H. D., Lichtman, S. M., Gajra, A., Ramani, R., Katheria, V., Zavala, L., & Hurria, A. (2014). Polypharmacy and Potentially Inappropriate Medication Use in Older Adults with Cancer Undergoing Chemotherapy: Effect on Chemotherapy-Related Toxicity and Hospitalization During Treatment. Journal of the American Geriatrics Society, 62(8), 1505-1512. https://doi.org/10.1111/jgs.12942
McDonald, E. G., Wu, P. E., Rashidi, B., Wilson, M. G., Bortolussi-Courval, É., Atique, A., Battu, K., Bonnici, A., Elsayed, S., Wilson, A. G., Papillon-Ferland, L., Pilote, L., Porter, S., Murphy, J., Ross, S. B., Shiu, J., Tamblyn, R., Whitty, R., Xu, J. Q., . . . Lee, T. C. (2022). The MedSafer Study-Electronic Decision Support for Deprescribing in Hospitalized Older Adults A Cluster Randomized Clinical Trial. JAMA Internal Medicine, 182(3), 265-273. https://doi.org/10.1001/jamainternmed.2021.7429
Oguz, E., Alasehirli, B., & Demiryurek, A. T. (2015). Evaluation of the attitudes of the nurses related to rational drug use in Gaziantep University Sahinbey Research and Practice Hospital in Turkey. Nurse Education Today, 35(2), 395-401. https://doi.org/10.1016/j.nedt.2014.10.011
Page, R. L., II, Linnebur, S. A., Bryant, L. L., & Ruscin, J. M. (2010). Inappropriate prescribing in the hospitalized elderly patient: Defining the problem, evaluation tools, and possible solutions. Clinical Interventions in Aging, 5, 75-87.
Patel, S. J., & Saiman, L. (2012). Principles and Strategies of Antimicrobial Stewardship in the Neonatal Intensive Care Unit. Seminars in Perinatology, 36(6), 431-436. https://doi.org/10.1053/j.semperi.2012.06.005
Sağlık Bakanlığı. (2020). Sağlıkta kalite standartları: Hastane (Sürüm 6.1). Sağlık Hizmetleri Genel Müdürlüğü, Sağlıkta Kalite, Akreditasyon ve Çalışan Hakları Dairesi Başkanlığı. https://dosyamerkez.saglik.gov.tr/Eklenti/41258/0/skshastane-seti-s-61–09082021pdf.pdf
Schuler, J., Dückelmann, C., Beindl, W., Prinz, E., Michalski, T., & Pichler, M. (2008). Polypharmacy and inappropriate prescribing in elderly internal-medicine patients in Austria. Wiener Klinische Wochenschrift, 120(23-24), 733-741. https://doi.org/10.1007/s00508-008-1089-z
Scott, I. A., Pillans, P. I., Barras, M., & Morris, C. (2018). Using EMR-enabled computerized decision support systems to reduce prescribing of potentially inappropriate medications: a narrative review. Therapeutic Advances in Drug Safety, 9(9), 559-573. https://doi.org/10.1177/2042098618784809
Tamblyn, R., Huang, A., Perreault, R., Jacques, A., Roy, D., Hanley, J., McLeod, P., & Laprise, R. (2003). The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care. Canadian Medical Association Journal, 169(6), 549-556.
Van Huizen, P., Kuhn, L., Russo, P. L., & Connell, C. J. (2021). The nurses' role in antimicrobial stewardship: A scoping review. International Journal of Nursing Studies, 113, Article 103772. https://doi.org/10.1016/j.ijnurstu.2020.103772
Source verification and AI use statement
Source verification. All 17 references were generated programmatically from the Web of Science records of the corpus, so authors, year, title, journal and DOI match the records exactly; every in-text citation was cross-checked by code against the reference list. Claims were checked against the record abstracts; full texts were not read. The SKS Hospital Set (Version 6.1) is the only source outside the corpus; it was accessed and read for this chapter.
AI use statement. Claude (Anthropic) was used to merge and de-duplicate the Web of Science exports, assign records to sub-topics, compute the bibliometric indicators and figures, and draft the text under the author’s instructions. The author is responsible for the final content.
Data and supplementary material
Supplementary file S1 (Excel) lists the 245 records of this chapter (authors, year, title, journal, DOI, title match flag), together with the full screening log of the 4948-record corpus and the citation verification report. The list is not reproduced here; it is available from the author on request.
← Chapter 2: The Hospital FormularyChapter 4: Drug Interactions and Parenteral Compatibility →